Enhancing clinical trial development for pediatric kidney diseases

Schnaper, H. W.; Flynn, J. T.; Gross, C.; Cropp, A. B.; Dehmel, B.; Patel, L. B.; Greenbaum, L. A.; Houtsmuller, E.; Kaskel, F.; Moxey-Mims, M.; Nowak, K.; Silverstein, D.; Thompson, A.; Yao, L.; Darsey, E.; Smoyer, W. E.

Pediatr Res. 2017 Aug 31; 82(5):727-732


The conduct of clinical trials in small pediatric subspecialties such as pediatric nephrology is hampered by both clinical demands on the pediatric nephrologist and the small number of appropriate patients available for such studies. The American Society of Pediatric Nephrology Therapeutics Development Committee (TDC) was established to (1) identify the various stakeholders with interests and/or expertise related to clinical trials in children with kidney disease and (2) develop more effective partnerships among all parties regarding strategies for successful clinical trial development and execution. This article discusses the rationale, structure, and function of the TDC, the status of progress toward its goals, and the insights gained to date that may be useful for other subspecialties that face similar challenges.

Read More on PubMed